Your Missing Links Are Here (9 April 2021)

Some of the best stuff we picked up around the internet

By: Karen O'Hanlon Cohrt - Apr. 9, 2021

Top picks

Industry

Research

Clinical trials and regulations

Conferences and webinars

  • On 21st April 2021, CRISPR Medicine News will host its very first webinar and attendance is open to all. The webinar’s two speakers will explore the topic ‘Certainty after CRISPR’, looking at the expected and unexpected events that may occur during CRISPR experiments. Find out more and register to attend here.
  • Registration is still open for the annual CRISPR conference to be held virtually in June 2021. Abstract submission closes at the end of next week. Find programme and registration details here.
  • Genetic conditions rewire our bodies - but science is learning to unpick them. In this episode of RAZOR Science Show, Frankie McCamley speaks to Dr Leslie Gordon, founder of the Progeria Research Foundation that led the discovery of the exact mutation behind progeria, opening the door for possible gene therapies. Watch the episode here. David Liu's group at Broad institute of MIT and Harvard has made major advances towards curing progeria with base editing technology. Check out our recent interview with David Liu to learn more about this work.

Funding

Podcasts and interviews

  • David Liu, Professor at Harvard, the Broad and Howard Hughes Medical Institute talks The Sheekey Science Show about th future of CRISPR (base & prime) and epigenome editing. Watch the recording here.
  • Walter Isaacson, author of recent book ‘The Code Breaker’ talks to Ezra Klein about the implications of humanity’s awesome, terrifying takeover of evolution in last week’s Ezra Klein Show. Listen in here or read the podcast transcript here.
  • CRISPR Therapeutics CEO Samarth Kulkarni joins the Bid podcast to discuss how the company has advanced clinical trials for CRISPR-based therapies for sickle cell disease, beta thalassemia and cancer. Listen in here.

Review

Tags

HashtagArticleHashtagMissing linksHashtagNews

CLINICAL TRIALS
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Non-small Cell Lung Cancer,NSCLC, (NCT03525782)
Sponsors:
First Affiliated Hospital of Guangdong Pharmaceutical University
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Prostate Cancer, (NCT03525652)
Sponsors:
The First Affiliated Hospital of Guangdong Pharmaceutical University
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine